These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9306256)

  • 1. Effects of thyrotrophin-releasing hormone tartrate and its sustained release formulation on cerebral glucose metabolism in aged rats.
    Nakayama T; Nagai Y
    J Pharm Pharmacol; 1997 Sep; 49(9):884-91. PubMed ID: 9306256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TRH analog (DN-1417): effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-[14C]glucose method.
    Nagai Y; Narumi S; Miyamoto M; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1983 Jun; 33(3):635-45. PubMed ID: 6413736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
    Nakayama T; Nagai Y
    Jpn J Pharmacol; 1996 Nov; 72(3):241-6. PubMed ID: 8957685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice.
    Miyamoto M; Hirai K; Heya T; Nagaoka A
    Eur J Pharmacol; 1994 Dec; 271(2-3):357-66. PubMed ID: 7705436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic abnormalities caused by 3-acetylpyridine in the cerebral motor regions of rats: partial recovery by thyrotropin-releasing hormone.
    Kinoshita K; Watanabe Y; Asai H; Matsuoka Y
    Jpn J Pharmacol; 2000 Apr; 82(4):295-300. PubMed ID: 10875748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thyrotropin-releasing hormone (TRH) on local cerebral glucose utilization, by the autoradiographic 2-deoxy[14C]glucose method, in conscious and pentobarbitalized rats.
    Nagai Y; Narumi S; Nagawa Y; Sakurada O; Ueno H; Ishii S
    J Neurochem; 1980 Oct; 35(4):963-71. PubMed ID: 6778968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats.
    Ogata A; Nagashima K; Yasui K; Matsuura T; Tashiro K
    J Neurol Sci; 1998 Aug; 159(2):135-9. PubMed ID: 9741396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thyrotropin-releasing hormone on pentobarbitone-induced sleep in rats: continuous treatment with a sustained release injectable formulation.
    Hashimoto T; Wada T; Fukuda N; Nagaoka A
    J Pharm Pharmacol; 1993 Feb; 45(2):94-7. PubMed ID: 8095539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A TRH analog (DN-1417). Antagonistic effects on reserpine-induced decreases in local cerebral glucose utilization and cerebral monoamine levels].
    Nagai Y; Narumi S; Saji Y; Nagawa Y
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):315-26. PubMed ID: 3928465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-cocaine on local cerebral glucose utilization in the rat.
    London ED; Wilkerson G; Goldberg SR; Risner ME
    Neurosci Lett; 1986 Jul; 68(1):73-8. PubMed ID: 3725217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer-344 rats.
    Soncrant TT; Holloway HW; Greig NH; Rapoport SI
    Brain Res; 1989 May; 487(2):255-66. PubMed ID: 2731046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood level and brain distribution of thyrotropin-releasing hormone (TRH) determined by radioimmunoassay after intravenous administration in rats.
    Nagai Y; Yokohama S; Nagawa Y; Hirooka Y; Nihei N
    J Pharmacobiodyn; 1980 Oct; 3(10):500-6. PubMed ID: 6782229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of regional cerebral blood flow to intravenous administration of thyrotropin releasing hormone in aged rats.
    Inanami O; Ohno K; Sato A
    Neurosci Lett; 1992 Aug; 143(1-2):151-4. PubMed ID: 1436660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on thyrotropin-releasing hormone-like immunoreactivity in the cerebral cortex and hippocampus of aged rats.
    Shinoda M; Okamiya K; Toide K
    Jpn J Pharmacol; 1995 Nov; 69(3):273-6. PubMed ID: 8699636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular administration of thyrotrophin-releasing hormone (TRH) suppresses prolactin secretion and synthesis: a possible involvement of dopamine release by TRH from rat hypothalamus.
    Ikegami H; Jikihara H; Koike K; Morishige K; Kurachi H; Yamamoto N; Hirota K; Miyake A; Tanizawa O
    J Endocrinol; 1992 Apr; 133(1):59-66. PubMed ID: 1355520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis.
    Giovannini MG; Casamenti F; Nistri A; Paoli F; Pepeu G
    Br J Pharmacol; 1991 Feb; 102(2):363-8. PubMed ID: 1901747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related differences in the spontaneous and thyrotropin-releasing hormone-stimulated release of prolactin and thyrotropin in ovariectomized rats.
    Wang PS; Liu JY; Hwang CY; Hwang C; Day CH; Chang CH; Pu HF; Pan JT
    Neuroendocrinology; 1989 Jun; 49(6):592-6. PubMed ID: 2505153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methiothepin reduces glucose utilization in forebrain regions of awake rats.
    Ricchieri GL; Soncrant TT; Holloway HW; Rapoport SI
    Psychopharmacology (Berl); 1987; 93(4):449-56. PubMed ID: 3124178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.